Higher EPHA2 expression has been previously associated with an increased probability of metastasis in several types of tumors, such as in non-small lung cell carcinoma (NSCLC), prostate cancer, and gastric adenocarcinoma [37,38,39]. The gene discussed is EPHA2; the disease is prostate carcinoma.